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Abstract
The use of assisted reproductive technology (ART) is widespread, with
an estimated five million ART-conceived children born now worldwide.
Despite this marked increase in the use of ART, little is known about
the demographic consequences. We explore several dimensions of demo-
graphic consequences of ART. The proportion of ART-conceived babies
varies greatly across countries, and our analyses suggest that ART costs,
policies and regulations, and national norms and values are core determi-
nants of these differences. Based on a review of the literature, we conclude
that ART has a negligible impact on national fertility rates, thereby sug-
gesting that it is not an effective policy instrument to counter low fertility.
Furthermore, we show that the recent increase in twin births in Europe
can be attributed to ART usage. A case study of Italy reveals that ART
mothers were more likely to deliver prematurely, even when controlling
for maternal age.
Keywords: Assisted reproductive technologies, twin births, late childbear-
ing, ART success, ART at late ages
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1 Introduction
The use of assisted reproductive technology (ART) treatments has substantially
increased since the birth of the first child conceived via in vitro fertilization
(IVF) in 1978 (Steptoe and Edwards, 1978). Since this initial treatment, an
estimated five million ART children have been born worldwide, with this trend
continuing to accelerate over time. The number of ART births reached one
million in 2003 and by 2007 it climbed to 2.5 million, followed by a doubling
of that figure by the end of 2013. The number of ART cycles and transfers
worldwide likewise continues to grow (Adamson et al., 2013).
Despite this marked increase in the use of ART, little is known about the
demographic consequences of these treatments. In this report we broadly define
demographic consequences as the proportion of ART births and ‘net impact’ of
ART on national fertility levels, the effectiveness of ART usage at later ages, the
impact of ART on multiple births and differences in pregnancies and deliveries
of ART conceptions versus non-ART births. A comprehensive review of the
ART literature demonstrated that previous research has primarily focused on
the economic and policy-related consequences of ART (Mills et al., 2013), often
ignoring demographic questions.
This report asks and answers key questions that are highly relevant to pol-
icy makers, ART providers, and patients. Our central research questions ask:
Could ART treatments operate as an effective policy instrument to counter low
fertility? Why are there considerable cross-national differences in the propor-
tion of ART births across nations? How has ART usage in older mothers above
40 years increased over time and how effective is ART at these advanced ages?
Is it delayed childbearing or ART policies that related to the dramatic growth
in twinning and multiple births across time? How do ART users and preg-
nancies and deliveries differ from their non-ART counterparts? Which types of
treatments are more likely to result in a successful birth?
The motivation to study the demographic consequences of ART is spurred
by key fertility changes across most European societies, namely the postpone-
ment of births to advanced ages and fertility levels below replacement rates.
Since the late 1980’s, many European countries reached very low fertility lev-
els, referred to as ‘lowest-low’ fertility or the ‘postponement transition’ (Kohler
et al., 2002; Mills et al., 2011). This has recently been countered with a reversal
of the fertility decline in the early 2000’s in most countries, albeit with consider-
able heterogeneity (Balbo et al., 2013). These initial changes resulted in many
nations searching for policy solutions to counter low fertility, and searching for
ways to extend particularly women’s reproductive period, with ART often the
focus of this debate.
As ART became widespread, a debate emerged about its potential influ-
ence on fertility rates and, subsequently, whether its wider provision should be
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considered as a part of policies that can eventually boost fertility rates in low-
fertility countries and, even more radically—serve to alter broader population
trends, slow down the pace of population aging and prevent the population
from declining (Connolly et al., 2010; Grant et al., 2006; Hoorens et al., 2007;
Ziebe and Devroey, 2008). One report went as far as to argue that policies
stimulating ART use might be considered as a part of population policy mix to
“increase fertility in Europe” (Grant et al., 2006). The most radical view was
expressed by Thaele and Uszkoreit (2007), who suggested that ART could be
a “‘tool’ in combating negative population growth in countries with declining
birth rates.” Others, however, have expressed more skepticism towards this per-
spective (Lassen et al., 2012; Leridon, 2004; Leridon and Slama, 2008; te Velde
et al., 2008).
The aim of this report is to document the broader demographic consequences
related to the increased usage of ART and is divided into four central research
aims. First, we answer the question of whether ART could be a useful policy
response to counter low fertility. We achieve this by examining the proportion of
ART births across countries, potential reasons for large cross-national differences
and consider the ‘net impact’ of ART on national fertility rates. Recent research
has shown that ART utilization varies greatly between countries (Chambers
et al., 2014; Kocourkova et al., 2014). We will explore the ensuing differences in
ART birth rates across countries and explore potential hypotheses and correlates
related to ART birth rates to foster an understanding the differences emerging
between countries.
Second, we examine ART usage at later ages, how this varies across countries,
and most importantly, examine how effective ART treatments are at advanced
ages. The postponement of childbearing has been a striking factor across many
European countries (Mills et al., 2011), but it remains unclear as to whether
there has been an increase of users of very advanced ages above 40, how this
varies by country and type of treatment and how effective treatments are at
older ages. In this section we likewise explore individuals’ self-reported con-
ceptions of their own levels of infertility, an aspect that is often ignored in the
literature. The recent debate about the benefits and downsides of so-called so-
cial freezing and move of companies such as Google and Facebook to pay for
the cryopreservation of oocytes for later IVF for non-medical reasons (Tran,
2014) reflects the desire of many women (and their employers) to use ART as a
means to reconcile employment and childbearing. The substantial effects of the
introduction of oral contraception of women’s careers—what Goldin and Katz
(2002) termed ‘the power of the pill’—might have created similar expectations
for ART, and it is questionable whether ART can fulfill those expectations with
respect to women’s career and childbearing reconciliation. In order to shed light
onto this issue, we compare ART usage rates among different age groups across
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European countries, distinguishing between different types of ART treatments.
Furthermore, we look at the success rates of ART treatments over age groups
and across countries to gauge how effective ART is for different groups.
Thirdly, we look at the explicit demographic consequence of ART treat-
ments, namely linking the growth in multiple births to ART treatments. While
multiple births are an important health risk both for children and their moth-
ers, the development of the multiple birth rate also highlights the importance
of ART regulation (Felberbaum, 2007). In this section we ask whether twinning
rates have grown over time across Europe and how this might be related to
delayed childbearing and ART policy. Here we link our findings to our previ-
ous report which examined the regulatory and economic aspects of ART (Mills
et al., 2014a).
As we note in our analyses until now, we are often left with aggregated
macro-level data on ART rates and usage, resulting in an inability to link it to
individual characteristics or outcomes. The fourth and final part of this report
overcomes these problems by using micro-level individual data from Italy in
order to ask key questions that macro-data evade. Here we are able to examine
the individual characteristics of ART mothers and whether there is variation by
the type of ART and probability to have a successful birth.
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2 The proportion of ART births and net impact
of ART on fertility rates
2.1 Proportion of ART births versus ‘net impact’ on fer-
tility rates
This report is based on data that stem from two different sources. Firstly, we
present data on ART regulation across a large number of countries. Secondly,
we make use of selected measures from large-scale survey data to present the
social context in which ART regulation is taking place. The data set assembled
for this report is publicly available, including a technical manual that describes
all measures, which will allow readers to conduct further analyses.
This section first examines the ART contribution to the total number of
births, followed in the last section by an examination of the contribution of the
‘net impact’ of ART on national fertility rates. The ‘net impact’ represents
the difference between the observed number of births and a hypothetical one
achieved in the absence of ART treatments, which is a more accurate means to
examine whether ART has a strong impact on fertility and demographic trends.
We explain the factors of why the net impact might be smaller than the simple
proportion of ART live births shortly.
Important shortcomings of the data that we examine in this section also need
to be acknowledged, as some countries do not register all ART cycles properly
and some pregnancies might be lost from observation making it impossible to
determine their outcome (Kupka et al., 2014). Furthermore, some women travel
abroad to undergo ART treatments (Shenfield et al., 2010), which is responsi-
ble for additional misclassifications of births. Reasons for seeking cross-border
care are manifold, ranging from attempts to access treatments that are pro-
hibited in the country of origin (e.g. German couples desiring IVF of donated
eggs, Bergmann (2011), or lesbian couples and single women going from France
to Belgium to receive IVF, van Hoof et al., 2015), access difficulties (e.g. UK
couples going abroad to avoid long waiting lists, Culley et al., 2011), to bet-
ter expected quality and previous failed treatments in the country of residence
(Shenfield et al., 2010). Shenfield et al. (2010) report that a conservative es-
timate of cross-border reproductive care (i.e. crossing country borders in order
to undergo ART) in 2008/2009 would be one of 11,000–14,000 patients and
24,000–30,000 treatment cycles in Europe. When confronted with the number
of ART cycles (2008: 532,000; 2009: 537,000) and aspirations (2008: 340,000;
2009: 383,000) counted in Europe at that time (Ferraretti et al., 2012, 2013),
this is a small, yet substantial share of patients and cycles.
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2.2 Cross-national differences in proportion of ART births
to all births
Figure 1 reports recent data for those European countries considered to have the
most complete data registration of ART treatments, in addition to the United
States for comparative purposes. The Figure reveals substantial variation be-
tween countries. In Denmark and Slovenia, the share of ART children among all
births has surpassed five per cent. In Iceland, Norway, Estonia, and Belgium,
the share is four per cent or slightly above. Countries where ART births are
least prevalent are Turkey, Moldova, Poland, Ireland and the United States,
with a share of less than 1.5 per cent. We now turn to possible substantive
reasons for this variation by country.
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Note: Data refer to 2010 or latest available (no earlier than 2007)
Figure 1: Cross-national differences in ART birth rates
Sources: De Mouzon et al. (2012); Ferraretti et al. (2012, 2013); Kupka et al. (2014); Sunderam
et al. (2013)
2.3 Understanding cross-national differences in national
ART levels
How can these differences in the proportion of the ART births between the
countries be understood? There are five central hypotheses that can be explored
in order to understand and interpret these differences, namely whether they are
related to: postponement, the demand for children (using a proxy of the overall
fertility rate), country affluence (and thus lower treatment provision) and the
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related aspect of affordability and finally, ART policy measures. In this section,
we correlate aggregate ART success levels with macro-level indicators to explore
associations. We recognize the shortcomings of this approach and inability to
make causal statements, but considering the lack of micro- and longitudinal data
of a cross-national comparative nature, we are still able to indicate plausible
relationships and outline future areas of research.
2.3.1 Fertility postponement
The first simple hypothesis is that late childbearing in the form of a late av-
erage age at first birth would result in higher national levels of ART. Figure 2
plots the mean age at mother’s first birth by the percentage of ART infants,
showing that there is no meaningful correlation. For countries with a mean age
at first birth between 28 and 29 years, the percentage of ART infants ranges
from about one per cent (Ireland) to about six per cent (Denmark). This cor-
roborates the finding by Kocourkova et al. (2014), who showed that ART use
in European countries was not correlated with Lesthaeghe and Neidert’s (2006)
fertility postponement index. One reason for this lack of an association might
be related to the low effectiveness of ART when attempting late childbearing,
which we explore in detail in the next section. In other words, since our measure
is of successful live births, we may be missing unsuccessful ART treatments that
did not result in a live birth, particularly of older women.
2.3.2 Changes in the demand for children: total fertility rate
Another hypothesis is that the national levels of ART usage might be related
to the overall growth in the increased demand for children, in which the total
fertility rate (TFR) can be used as a proxy. Figure 3 demonstrates that we
are in fact able to show that there is an association with ART usage (and
subsequently ART birth rates) in countries that also have a high TFR. This
supports a recent finding by Kocourkova et al. (2014) who suggest that increases
in ART utilization increased in tandem with the fertility rates in many European
countries. It is vital to note, however, that the results by these authors and our
macro-level associations are unable to specify any causal direction of the effect.
While studies have suggested that the effect of ART births on fertility rates are
not negligible (Hoorens et al., 2007; Sobotka et al., 2008), both trends could
also be driven by an increasing demand for children in many countries in the
last years.
2.3.3 Country affluence
In addition to arguments related to postponement and total fertility rates, an
additional hypothesis is that varying national degrees of ART usage might be
12
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Figure 2: Correlation of mother’s age at first birth and ART birth rates
Sources: De Mouzon et al. (2012), Eurostat (2014b, demo find), Ferraretti et al. (2012, 2013);
Kupka et al. (2014).
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explained by the level of country affluence. Here the explanatory mechanism is
that the lowest-income countries of Europe may have a lower provision of ART
treatments for economic reasons.
Figure 4 plots the percentage of ART infants by the GDP per capita and
demonstrates that the cross-country differences in ART rates cannot be ex-
plained by country affluence. High-income countries such as Norway, Switzer-
land, the US and Denmark vary greatly in the share of ART births, ranging
from one to two per cent in the US and Switzerland to four to nearly six per
cent in Norway and Denmark. Among low-income countries, the variation is
also substantial: from less than one per cent in Turkey to more than three per
cent in Macedonia. This indicates that the wealth of countries is clearly not
the driving force behind ART birth rates. This result is in line with the recent
finding by Chambers et al. (2014), who show that country affluence is unrelated
to ART utilization.
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Figure 4: Correlation GDP per capita and ART birth rates
Sources: De Mouzon et al. (2012), Eurostat (2014a, nama gdp c), Ferraretti et al. (2012,
2013); Kupka et al. (2014).
2.3.4 Affordability of treatments
It might be, however, that GDP and national levels of affluence are simply too
crude of an indicator to capture the economic factors that impact national levels
of ART usage. A more direct measure is the affordability of ART treatments,
which is defined as the net cost of a fresh ART cycle as a percentage of aver-
14
age annual disposable income (Chambers et al., 2014). We therefore propose
an additional hypothesis, which is that the more affordable a treatment is for
individuals in a particular country; the more likely they are to utilize these
treatments. In other words, we argue that a major driving force of ART birth
rates is related to the affordability of ART treatments (Chambers et al., 2013,
2009; Dunn et al., 2014; Mladovsky and Sorenson, 2010). Figure 5 plots the
national levels of affordability against the ART birth rates and forcefully un-
derlines the importance of affordability of ART treatments for ART utilization.
The negative relationship between costs and ART birth rates clearly holds, even
when excluding the US—where costs for ART treatments can be particularly
high—from the analysis. ART utilization does not appear to be impacted by
the overall level of affluence in a country, but rather it is the costs for individuals
and couples which drive utilization and birth rates.
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Figure 5: Correlation ART costs and ART birth rates
Sources: Chambers et al. (2014); De Mouzon et al. (2012); Ferraretti et al. (2012, 2013);
Kupka et al. (2014).
Mills et al. (2014b) likewise noted considerable variation across countries
regarding whether ART was covered or not covered by national, private or both
types of insurance, which is inherently related to affordability and ability to
engage in a treatment. For many European countries, ART was either partially
or completely covered as part of the national health plan of a country. Other
countries, however, such as Poland and the U.S. had coverage by private in-
surance with others having even no coverage (Ireland, Latvia, Lithuania, and
15
Romania).
2.3.5 ART policies and cultural values
We also anticipate that national ART policies, which are often intertwined with
cultural values, underlie the disparities in ART usage across countries. The pre-
vious report from this Work Package explored this aspect in detail and demon-
strated how national ART policies and cultural values impacted ART usage
(Mills et al., 2014a). The report noted a striking lack of coherence and even
contradiction regarding ART policies, within countries and over time. Although
there has been a general move to more formalized legislation and statutory laws,
considerable variation still exists. As we will touch upon shortly in relation to
the rise of multiple births, one striking policy change has been the move to more
stringent regulations regarding the transfer of embryos over time, which started
in the early to mid-2000s, first in the Scandinavian countries. As explored in
more detail in the previous deliverable in this Working Package (Mills et al.,
2014a), ART usage and specific policies such as the number of embryos that
are transferred is highly correlated to national religious, cultural and political
values regarding whether a fertilized embryo is a human being.
Figure 6 reveals that there is also a correlation between attitudes about
the moral status of human embryos and the share of ART births in a country.
The moral status of human embryos was assessed with the agreement to the
statement “Immediately after fertilization the human embryo can already be
considered to be a human being” (Eurobarometer 73.1 (2010), European Com-
mission, 2012). Agreement was measured on a four-point scale with the options
“Totally agree,” “Tend to agree,” “Tend to disagree,” and “Totally disagree.”
For the analysis below, we calculated the average percentages of respondents
tending to disagree and totally disagreeing to the statement that embryos are
human beings right after fertilization.
Indeed, in countries where a lower moral status is attached to embryos,
ART birth rates are higher. Given the fact that ART techniques require the
handling of embryos and often ethically charged actions such as elective single
embryo transfer (Thurin et al., 2004), this association is not surprising. What
is remarkable is the strength of the association; it is comparable to the size of
the association of ART births and affordability of ART treatments (Figure 5).
Figure 7 however reveals that the correlation between views on the moral
status of an embryo in a country are not as clear-cut as they appear in Figure 6.
When embedded in a specific example, the correlation is considerable weaker.
Here, agreement to the statement “We have a duty to allow research that might
lead to important new treatments, even when it involves the creation or use
of human embryos” (Eurobarometer 73.1 (2010), European Commission, 2012)
was assessed. Again, response options were “Totally agree,” “Tend to agree,”
16
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Figure 6: Correlation moral status of an embryo and ART births
Sources: De Mouzon et al. (2012); European Commission (2012); Ferraretti et al. (2012, 2013);
Kupka et al. (2014).
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“Tend to disagree,” and “Totally disagree.” For the analysis, we clculated the
average percentages of respondents tending to agree and totally agreeing to the
statement that we have a duty to allow research that creates or uses human
embryos for the sake of medical progress. While the overall trend in the scat-
terplot is positive, the fit of the regression line is far from perfect. A reason
for the difference between the findings in Figure 6 and Figure 7 might be that
people’s opinions on the moral status of human embryos are more complex or
more diffuse than the survey items at hand can capture. Also, the item in Fig-
ure 7 brings in very different assumptions than the one in Figure 6, in that it
is open for the respondents’ interpretation what a “duty” or “important new
treatments” constitute, also using and creating human embryos have different
moral implications that are being conflated in the item in Figure 7.
In sum, we were able to show here and in other work (Mills et al., 2014a;
Präg and Mills, 2017b,a; Präg et al., 2017; Präg and Mills, 2017c) that both
ART usage as well as ART birth rates are correlated with ART costs, ART
regulation, as well as norms and values across countries, in complex ways that
need further elucidation.
2.4 ART birth rates over time
Figure 8 presents the development of ART birth rates from 1997 to 2010 in
selected countries. While we have seen great heterogeneity in the level of ART
births between countries (Figure 1), the trend over time is unequivocal. In all
countries we observe an upward trend in the past decade. The only exception is
Germany, where a change in reimbursement regulations in 2004 caused a drop
in ART uptake.1 Until 2004, the German public health insurance system paid a
hundred per cent of up to four treatment cycles; since then, only 50 per cent of
the costs of up to three cycles are covered (Fauser and Devroey, 2011, p. 206).
The drop in ART births again underlines the importance of affordability of ART.
But since the drop in 2004, the trend has been upward. Between countries, there
are differences in the strength of the upward trend. The slope in some countries
such as France, the UK, and the US is rather flat. For instance, in the UK and
in France, the share of ART births roughly doubled over a period of 14 years.
In other countries, the slope is even steeper, such as in Belgium, where the rate
increased from 1.5 per cent in 2001 to four per cent in 2010.
2.5 Contribution of ART to the net birth rates
Focusing on the ‘net impact’ rather than the simple proportion of ART live
births is essential to avoid making exaggerated claims about the policy rel-
1It is likely that the drop in 2004 was inflated in the sense that couples who were antic-
ipating the change in regulations underwent treatment in 2003 which they would have only
had later if there had not been a policy change.
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evance of ART treatments as a solution for low-fertility societies. The ‘net
impact’ is defined as the difference between the observed number of births and
a hypothetical one achieved in the absence of ART treatments.
Two factors make this ‘net impact’ smaller than the simple proportion of
ART live births. First, some couples undergoing ART would eventually achieve
spontaneous conception. Brandes et al. (2011) were for instance able to show
that of 437 subfertile couples seeking ART in a fertility clinic, 56 per cent con-
ceived before treatment, although those couples had on average experienced two
years of unexplained subfertility before that. Troude et al. (2012) and Steures
et al. (2006) report similar findings. A review of figures from previous studies
(Cahill et al., 2005; Eijkemans et al., 2008; Osmanagaoglu et al., 2002; Pinborg
et al., 2009) suggests that there is quite a range of estimates in the literature
when it comes to naturally conceived pregnancies among couples undergoing
ART treatment and that it is safe to say that well above ten per cent and pos-
sibly close to twenty per cent would eventually become pregnant without the
treatment (Mills et al., 2013).
Second, ART partly leads to unintended or unplanned ‘extra’ births due to
very high rates of multiple deliveries. Thus, a portion of ART births would be
eliminated if unintended twin and triplet births had not inflated the number of
observed ART infants. This development is already under way with a spread
of single embryo transfers and the tendency of ART to result in more multiple
births is not constant over time and between countries (see also section 4). In
some countries the trend in ART moves away from multiple embryo transfer
to elective single embryo transfer (Maheshwari et al., 2011), however in many
parts of the world, including the US and Asia, multiple birth rates after ART
are still at 20–30 per cent (Templeton, 2010). While it seems straightforward to
calculate the contribution of multiple births due to ART (also see the section
on multiple births below), research has shown that not all multiple births after
ART are undesired (McLernon et al., 2010). Some parents want to have more
than one child, and having twins can be seen as a money-saving strategy when
faced with high costs for ART treatments. Furthermore, some women would go
back to ART to have another child through additional ART treatments (Mills
et al., 2013).
So far, only few studies tried estimating the contribution of ART to fertility
rates (Mills et al., 2013). Hoorens et al. (2007) took a simple approach that
did not account for the chance of spontaneous natural conception nor multiple
births and estimated that ART contributed to the period total fertility rate in
the United Kingdom .02 (from 1.62 without ART to 1.64 with ART) and .07
in Denmark (from 1.65 without ART to 1.72 with ART). Sobotka et al. (2008)
examined cohort fertility rates of Danish women. For women born in 1970, they
reached results similar to those of Hoorens et al. (2007) for the total fertility
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rate. The estimated net effect however, was considerably lower, ranging from
.04 to .06, conditional on the assumptions made regarding multiple births and
spontaneous conception. For the Netherlands, Habbema et al. (2009) arrived
at a higher estimate for the increase in period total fertility rate of .08 (from
1.79 to 1.86), however this increased would be cut by more than half if multiple
births were eliminated. For French women born in 1968, Leridon and Slama
(2008) estimated a .04 increase in the total fertility rate if all couples resorted
to ART within one to four years and a .02 increase if only half of the couples
did this. In sum, these studies reveal that any views that ART might have a
substantial and large effect on fertility rates are exaggerated.
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3 ART usage and effectiveness at later ages
Fertility postponement is one of the main drivers of low fertility in European so-
cieties. The average age at first birth has increased by about one year per decade
since the 1970’s in most OECD countries (Mills et al., 2011). Maternal age is,
however, the most important predictor of achieving pregnancy and successful
delivery (Dunson et al., 2004). While research has shown that there is a re-
markable variability in female reproductive aging (te Velde and Pearson, 2002),
female fertility traditionally ends with menopause. As te Velde et al. (1998)
illustrated, the number of follicles starts to decrease with age, with sharper
decreases starting at the age of 31, menopause at the average age of 45, and
fertility generally ending for most women in their early 40’s. Eijkemans et al.
(2014) report that the age at last birth is around 40–41 years across a range of
natural fertility populations.
The WHO defines infertility as the inability of a sexually active, non-contracepting
couple to achieve pregnancy in one year. One the one hand, this definition poses
problems with respect to measurement; on the other hand, research has shown
that couples who seek infertility treatment regularly conceive under conditions
of expectant management (Brandes et al., 2011; Steures et al., 2006; Troude
et al., 2012). Due to these considerable measurement problems, it is difficult
to obtain individual-level data regarding the timing of the onset of infertility.
For this reason, we first turn to recent and rare data that show individuals’
self-reported ideas about their own infertility.
3.1 Self-reported infertility by age groups and across coun-
tries
A recent albeit less precise approach to gauge infertility—taken by the Genera-
tions and Gender Survey (GGS, Vikat et al., 2007)—is to collect self-reports of
infertility directly from respondents in a survey. In the first wave of the GGS,
respondents were asked ‘Some people are not physically able to have children.
As far as you know, is it physically possible for you, yourself, to have a/another
baby?’ Figure 9 plots the percentage of (non-pregnant) women reporting that it
is ‘definitely not’ or ‘probably not’ possible to get pregnant over age groups and
countries. While all countries show a clear upward trend in (suspected) infertil-
ity over age groups, there is quite a variation in the slopes reported by women.
Whether these differences are rooted in different cultural beliefs about fertility
or reflect biological differences due to factors such as genetic dispositions (e.g.
for early menopause, endometriosis) is not possible to determine using the GGS
data.
Figure 10 shows the remarkable differences between countries for a partic-
ularly relevant group, the 35–39 year-olds. Whereas among French, Polish,
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Hungarian, Bulgarian, and Norwegian women the self-reported infertility rate
ranges around five per cent, in countries such as Austria, Romania, Belgium,
the Czech Republic it ranges around ten per cent, and in Russia and Georgia it
has clearly surpassed ten per cent. The lower panel of Figure 10 shows the same
rates as reported by 35–39 year-old men, however both absolute rates as well as
cross-national variability are lower than for women. In most countries the rate
of male self-reported infertility ranges well below or around five per cent. Only
in Germany and Norway the rate is higher than five per cent.
Infertility, particularly as it is perceived by individuals, is an important
driver of the demand for ART treatments. While the data show that women in
generally perceive infertility to increase with age, which is in line with the med-
ical literature (e.g. te Velde et al., 1998), there is substantial variation between
countries with respect to the pace of the perceived fertility decline. In how far
these differences reflect biological conditions, differences in the desire to have
children (e.g. women who are voluntarily childless will not be aware of the fact
that they are unable to conceive naturally), norms regarding older parents, and
differences in cultural reporting standards have to be left to future research.
Nonetheless, these differences should be kept in mind when interpreting cross-
country differences in ART demand and utilization.
3.2 Increase of women over 40 years receiving treatment
over time
Given the trend towards late childbearing, it is likewise interesting to explore
whether this fertility postponement has translated into increasingly older women
(i.e. over the age of 40) seeking ART treatments. Figure 11 reveals a growing
trend in the development of ART aspirations by women aged forty and older over
time and across different European countries.2 Unfortunately, data do not allow
us for a more detailed breakdown by higher ages. Most countries reveal indeed
an upward slope in the demand by older women for ART treatments, most
remarkably Iceland, Italy, and Denmark. In some countries, such as Sweden
and the UK, the increase is slower, whereas in other countries, such as Hungary
and France, the ART demand among older women remains largely stable over
time. This can reflect differences in access regulations to ART across countries
(Mills et al., 2014b).
Also, Figure 11 shows that there are stark differences in the level of ART
use among older women. Whereas in Poland or Portugal the share of women 40
and older using ART treatment is less than one out of a thousand, in countries
such as Norway, Switzerland, Denmark, and Italy, the shares are several times
of that.
2Aspirations are initiated ART cycles in which one or more follicles are punctured and
aspirated irrespective of whether or not oocytes are retrieved (Zegers-Hochschild et al., 2006).
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Figure 9: Self-reported infertility among old women by age group and country,
2005–2011
Source: Generations and Gender Survey (Vikat et al., 2007), own calculations.
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Figure 11: Increase in ART use (ICSI and IVF) among women age 40+, selected
countries, 1997–2010
Sources: De Mouzon et al. (2010, 2012); ESHRE (2001a,b, 2002, 2004, 2005, 2006, 2007,
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3.3 ART usage by age, country and type of treatment
The data used for Figure 11 do not allow us to distinguish between which type
of ART treatment women utilize. The most recent ESHRE data (Kupka et al.,
2014), however, allow us to distinguish this. Figure 12, Figure 13, Figure 14, and
Figure 15 present data on ART patients broken down by age, country, and type
of treatment. We can only distinguish between rather broad age categories,
namely women age 34 and below, 35 to 39 years of age, and 40 years and
above. Figure 12 reveals substantial variation across countries with respect to in
vitro fertilization (IVF) across countries. In Greece, Italy, Switzerland, Ireland,
Denmark, Lithuania, Iceland, Germany, and Spain, the share of patients age
40 and older is 20 per cent or greater, in other countries, such as Montenegro,
Poland, Kazakhstan, or the Czech Republic, it is less than ten per cent. Across
the countries under study, the average share of IVF patients 40 years and older
is 16.7 per cent, for those between 35 and 39 it is 37.6 per cent, and 45.6 per cent
of IVF treatments are administered to women aged 34 and younger.
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Figure 12: IVF patients by age and by country, 2010
Source: Kupka et al. (2014).
Among women undergoing intracytoplasmic sperm injection (ICSI) (Ny-
boe Andersen et al., 2008), the average across countries is similar (Figure 13,
17.3 per cent), but the distribution is slightly different. Here, Montenegro, which
has the youngest IVF patients, has among the oldest ICSI patients. Other coun-
tries where the share of ICSI patients that are 40 and older are above 20 per cent
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are again Italy, Greece, and Switzerland, but also Macedonia and Bulgaria. The
countries with the smallest share of ICSI patients aged 40 and older can be found
in Kazakhstan, Serbia, Norway, Moldova, and Poland, where shares are all be-
low ten per cent. Similar to IVF treatments, across all countries the share of
ICSI cycles among women 34 years or younger is 45.2 per cent, among those
between 35 and 39 it is 37.5 per cent, and, as mentioned above, among women
age 40 and older it is 17.3 per cent.
Figure 14 presents data on frozen embryo replacement (FER), a technique
used in repeated ART treatments (Stoop et al., 2014). It is common during
IVF/ICSI treatments to fertilize more than the oocytes required at the time.
Good quality embryos are then cryopreserved for later use, for instance when
the current ART attempt does not result in a successful delivery. Whereas in
Lithuania and Montenegro, FER is not practiced among women 40 and older,
in Switzerland twenty per cent of patients undergo FER. Ireland, the Czech
Republic, and Greece are also countries where FER is not uncommon among
patients forty years or older.
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Figure 13: ICSI patients by age and by country, 2010
Source: Kupka et al. (2014).
For egg donation (ED), the age distribution among patients is markedly
different. Egg donation is a technique that allows women who are unable to
produce their own oocytes to achieve pregnancy (Grossman et al., 2012; Keenan
et al., 2012; Paulson et al., 2002). Reasons for this can be premature ovarian
insufficiency (which often occurs spontaneously or related to cancer treatment)
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Figure 14: FER (frozen embryo replacement) patients by age and by country,
2010
Source: Kupka et al. (2014).
or because of a depleted ovarian reserve (and is related to female aging). Women
are transferred an oocyte of a donor and thus give birth to a child which does not
carry any of their own biological material. In some countries, such as Germany,
egg donation is outlawed. Figure 15 shows that women receiving ED are in most
countries indeed past the age of 40.
3.4 ART effectiveness at later ages
We now ask how ART use at higher ages translates into pregnancies and de-
liveries. Research has suggested that maternal age is a major predictor of an
ART pregnancy (Lintsen et al., 2007). Figure 16, Figure 17, and Figure 18
reveal two indicators of ART success by treatment type, age groups, and across
selected countries for which data is available. For women age 34 or younger,
pregnancy rates after IVF (Figure 16) are around thirty per cent in all countries,
sometimes (in Slovenia) as high as forty per cent. The delivery rate is usually a
few percentage points lower due to miscarriages and spontaneous abortions, but
sometimes (Spain and Germany), those differences are marked. When compar-
ing the pregnancy and delivery rates of women aged 34 or younger to those of
women between the ages of 35–39 years of age, a clear decline can be seen. In
virtually all countries (Sweden is an exception), the slope is even more negative
for women aged forty or older. After IVF, the pregnancy rate among women
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Figure 15: ED (egg donation) patients by age and by country, 2010
Source: Kupka et al. (2014).
40+ is only around ten per cent, which is in line with research from the US
(Malizia et al., 2009).
For ICSI success (Figure 17), the picture is virtually identical. In all coun-
tries, the success rates for women age 40 and older decline markedly. For FER,
shown in Figure 18, the age differences in ART success are less marked, how-
ever, the overall level of success is substantially lower. Pregnancy rates are often
around twenty per cent even for women 34 or younger.
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4 ART and multiple births
One possible demographic consequence of ART is an increase in the number of
multiple births. In the following analysis, we restrict our examination to twins,
as the data on triples and higher-order multiple births is relatively sparse. Both
more traditional hormonal treatments and multiple embryo transfers increase
the likelihood of a twin birth, however, other factors affect twinning rates as
well.
The specific relevance of multiple births for societies lies in the adverse out-
comes associated with them. Multiple births are a major health risk both for
mothers and children. Having twins is generally associated with more complica-
tions during pregnancy, such as ecotopic pregnancies, spontaneous miscarriage,
pre-eclampsia, placenta praevia, gestational diabetes, fetal growth restriction,
pre-eclampsia, and pre-term birth (Talaulikar and Arulkumaran, 2013). There
is a greater rate of caesarean sections for twin pregnancies. In addition, the
risk of postpartum depression increases (Choi et al., 2009) as well as the risk of
parental divorce (Jena et al., 2011). In general, the economic costs associated
with multiple pregnancies appear to be higher than singleton births (Chambers
et al., 2014).
4.1 Dramatic changes in twinning rates across Europe
It is well documented that the twinning rate has increased dramatically since the
early 1970’s in nearly all countries for which reliable data from vital statistics is
available (Hoekstra et al., 2008; Pison and D’Addato, 2006). The increase is so
strong that several European countries are now experiencing rates of twinning
that previously were only observed in Western and Central Sub-Saharan Africa,
which has the highest naturally occurring twin rates (Bulmer, 1970; Smits and
Monden, 2011). In Denmark, for instance, the twinning rate has more than
doubled between 1975 and 2001, from 9.6 to 21.2 twin deliveries per 1,000
deliveries. Also Estonia and Greece have twinning rates of more than 20. For
England and Wales, the rate increased from 9.9 to 16.1, in Germany from 9.2 to
17.2, and in France from 9.3 to 17.4. These last two trends are comparable to
the development in the United States, where the twin rate increased from 9.5
to 16.9. Figure 19 gives an overview of the trends in twinning for a selection
of countries over the last century up to the most recent year for which data is
available.
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Figure 19: Evolution of twinning rates in a selection of countries, 1900–2013
Source: Pison et al. (2015). Note: UK refers to England and Wales only.
4.2 Is delayed childbearing the driving factor behind twin-
ning rates?
Apart from ART, there are other factors that may also be driving the increase
in twinning. The most important factors affecting twin birth are maternal age,
number of children, and region or country (Hoekstra et al., 2008, partially re-
flecting genetic differences, ). A twin birth is more likely at higher maternal ages
and higher parities. While the average age at childbearing has changed dramat-
ically over the past thirty years (Mills et al., 2011), the number of children
among women who already have children has not changed as much. Also, there
is no reason to assume that the genetic propensity for twinning has changed in
this time period. Thus, part of the increase in twinning may be a result of the
shift to later births that we can observe throughout Europe and North America.
ART and delayed childbirth are likely to be the two most important drivers of
the increase twinning rates.
As an illustration, Figure 20 shows how maternal age was related to the
chances of a twin birth before ART was available, namely in 1965–1969. Clearly,
the frequency of spontaneously conceived twin deliveries varies with maternal
age. The pattern is very similar across the four countries presented in the Figure.
The twin rate increases with maternal age and is highest when a woman gives
birth between the ages of 35 and 39.
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Therefore, we may expect changes in the overall twinning rate when child-
bearing is delayed. Figure 21 illustrates the relationship for France. The Figure
shows the strong association between mean age at childbearing and the twinning
rate; both lines move virtually in lockstep.
4.3 Distinguishing between the effects of ART and de-
layed childbearing
The question now is how much of the increase in twining can be attributed to
delayed childbearing and how much to ART. Only if we had individual-level
data on twin status, maternal age, and ART, we would be able to determine
exactly which factor, ART or delayed childbearing, contributed how much to the
increase in twinning. Given only aggregate data on twin rates and information
on the distribution of maternal age, however, we can at least estimate how
much each factor has contributed to the change in twin rates. We have to
assume that the relationship between maternal age and the likelihood of a twin
birth—as shown in Figure 20—has not changed over time and is similar across
countries.
Taking France as an example, we can calculate the relative contributions of
ART and childbearing. The observed twinning rate for France was 9.4 in 1970
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Source: Pison et al. (2004).
and 16.3 in 2005. This means it has multiplied by a factor of 1.73 over 35 years.
To assess the contribution of delayed childbearing, we calculate what the in-
crease in twin rates, assuming only the age distribution at birth has changed.
The distribution of age at birth is taken from the Human Fertility Database
(HFD, 2014). Using the age-specific twin rates from Figure 20 (averaged over
the four countries) and applying them to the actual distribution of age at birth,
we find that the increase in twinning would had been far less: from 9.4 to 10.9,
a multiplication by 1.16. If we assume that delayed childbearing and other
factors are independent and combine their effects, we can conclude that other
factor—mostly ART—have been responsible for an increase of the twin rate
by a factor of 1.50 (1.16 × 1.50 = 1.73). In other words, the French twin
rate increased by about 16 per cent due to delayed childbearing and by about
50 per cent due to all other factors, most likely predominantly the use of ART.
We can apply the same logic to countries for which we have an actual twin
rates in the period 1970–2005 and for which we know the changes in the distri-
bution of age at birth. Figure 22 shows the results of such an analysis for twelve
countries. The countries are ordered by the absolute increase in the twin rate
that is associated with factors other than delayed childbearing. For the Czech
Republic, for instance, we estimate that factors other than delayed childbear-
ing are responsible for an increase in the twin rate (between 1970 and 2005)
of 64 per cent (or 1.64). Delayed childbearing is associated with an increase of
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Figure 22: Estimated increase of the twinning rate due to delayed childbearing
and to other factors (mainly ART) in selected countries, 1970–2005
Source: Pison et al. (2015). Notes: UK refers to England and Wales only. US from 1971–2005.
22 per cent (or 1.22). Of these twelve countries, the Czech Republic has the
strongest increase in twinning: 100 per cent (or 1.22 × 1.64 = 2.00). The twin
rate doubled from 9.6 to 19.2. Estonia had the smallest increase, merely 28
per cent. Only a small part of this overall increase by a factor of 1.28 can be
attributed to delayed childbearing (1.05). Most of the change is driven by other
factors (1.22), which we assume are mostly ART-related.
Figure 19 showed that some countries had a much stronger increase in twin
rates than others. Despite these big differences there is a remarkably strong
pattern in Figure 22: The increase due to late childbearing (the dark bar) is
always substantially smaller than the increase due to other factors (the light
bar). In all countries, the share of change in the total change due to delayed
childbearing is less than 50 per cent. In Sweden its share is highest at 45 per cent,
in Estonia it is lowest at 21 per cent. Across these countries, roughly only one-
third of the increase in twinning can be attributed to delayed childbearing. The
other two-thirds are most likely attributable to ART.
4.4 Multiple births and multiple-embryo transfer policies
Multiple-embryo transfer as well as ovarian stimulation were common practices
in the early years of ART (Dickey, 2007), however, with the mounting success
rates of ART treatments, the risks of multiple births are now a more prominent
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factor in the discussion of ART treatments (Chambers et al., 2013; Dunn et al.,
2014). Several methods to reduce multiple pregnancies are now gaining popu-
larity, such as single embryo transfer (SET) and increasing the time in culture
for the embryos to reach the blastocyst stage for transfer (Baruffi et al., 2009;
Gerris, 2009; Karlström and Bergh, 2007; Wang et al., 2010).
Figure 23 shows the development of the number of embryos transferred across
countries over time. It reveals a considerable degree of heterogeneity in the
development and level of single-embryo transfers. While there seems to be a
general trend towards single-embryo transfers, this is not without exception.
Countries with strong upwards slopes are Finland, Denmark, Sweden (where
the medical profession moved to SET without any intervention by other regu-
lating bodies), and Belgium (who has reinforced single-embryo policies by tying
them to reimbursement) (Jones et al., 2007). In Germany, where elective single
embryo transfer is outlawed, a trend from three-embryo to two-embryo trans-
fers is visible. Germany and Spain are also two countries where governments
abolished transferring more than three embryos (Cook et al., 2011), which is re-
flected in the Figure. In other countries, the slope is flatter and also the overall
level is much lower. Moving from aggregated country-level data, we now turn
to an individual case study of Italy where we are able to explore more nuanced
findings at the individual level.
Figure 23: Development of single embryo transfers across countries
Source: De Mouzon et al. (2010, 2012); ESHRE (2001a,b, 2002, 2004, 2005, 2006, 2007, 2008);
Ferraretti et al. (2012, 2013); Kupka et al. (2014); Nyboe Andersen et al. (2009).
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5 ART and pregnancy outcomes: The case of
Italy
5.1 Background and aim of case study
In Italy as in other countries, the postponement of childbearing caused a rise in
late fertility, in childlessness levels, and use of assisted reproductive technology.
Despite a restrictive legislation in Italy, ART has created new opportunities for
many Italian couples who were previously considered unable to have children
at later ages. In 2010, 1.7 per cent of all live births in Italy were the result of
ART treatments (Figure 1). While this is still comparably low in international
terms, the share of ART births among all live births in Italy nearly doubled
from 2006 to 2010 (Figure 8). Also, it is essential to note that the share of
Italians seeking fertility treatment abroad is high due to restrictive legislation
(Mills et al., 2014b; Robertson, 2004; Turone, 2004, 2005, 2009; Zanini, 2011),
making this figure likely an underestimation of its true value. The Osservatorio
per il Turismo Procreativo (Observatory for Procreative Tourism)—managed by
the Italian Association CECOS (Center for Study and Preservation of Eggs and
Sperm)—estimates that around 4,000 Italian couples undertook cross-border
reproductive care in 2011.
While one pathway by which ART can lead to detrimental outcomes for chil-
dren is multiple births, studies have also shown that ART singleton births can
be at a disadvantage to their naturally conceived counterparts. Numerous stud-
ies already point in the direction of usually small, yet considerable risks for ART
children (Hart and Norman, 2013a,b; Helmerhorst et al., 2004; Pinborg et al.,
2013; Sazonova et al., 2011; Scherrer et al., 2012; Talaulikar and Arulkumaran,
2013; Williams and Sutcliffe, 2009) and this field of research is generally seen
as very important (Grace and Sinclair, 2009; Kissin et al., 2014). The lack of
proper individual-level data to study outcomes of ART conception is one of the
main reasons that impede demographic studies in this field. In our case study
on Italy, we contribute to closing this knowledge gap, drawing on a combination
of administrative data sources in order to answer to two research questions.
First, we distinguish between important characteristics (e.g. age, education,
citizenship) distinguishing mothers who underwent ART treatment from those
who have not used ART. Secondly, we investigate whether ART treatment (dis-
tinguishing between different types of ART) is associated with the probability
to have a live birth versus an adverse outcome (miscarriage or stillbirth).
5.2 Data and methods
For our analyses, we draw on two different data sets: The Birth Assistance Cer-
tificate (CEDAP) register and the Register of Miscarriages (AS), both collected
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in 2009, respectively by the Ministry of Health and the Italian Statistical Of-
fice ISTAT. CEDAP is a register running since 2002 containing about 550,000
annual deliveries, drawing on hospital information. It contains information on
parents’ socio-demographic background (age, residence, citizenship, marital sta-
tus, education, labor market status), mother’s reproductive history (parity, live
births, stillbirths, previous induced abortions, previous miscarriages), pregnancy
characteristics (medical examinations, ultrasound examinations, gestational age
etc.), assisted reproductive technology (by type), delivery (place of birth, mode
of delivery, date of birth, plurality etc.), neonatal characteristics (sex, external
genitals, birth weight, length, vital status, neonatal presentation, etc.), fetal
mortality, and the presence of malformations.
AS comprises information on miscarriages occurred in both private and pub-
lic hospital since 1979. Miscarriages that occurred at home are not included in
AS. Furthermore, AS contains women’s socio-demographic information (age,
residence, citizenship, marital status, education, labor market status), repro-
ductive history (live births, stillbirths, previous induced abortions, previous
miscarriages), on miscarriage (gestational age, kind of operation, analgesic ther-
apy, length of stay in hospital, and complications. Since 2000, information on
ART treatments is also included.
In order to distinguish the differential characteristics distinguishing mothers
who gave birth after ART treatment from those who have not used ART, a logit
model is estimated, using the CEDAP data set. Furthermore, using another
logit estimation we show whether ART treatments (according to the kind of
treatment) increase the likelihood of having a stillbirth or miscarriage instead
of a live birth.
Unfortunately, the data come with some restrictions. CEDAP contains no
information at all on the Molise region. In the Lazio region, information on ART
is missing. Large shares of missing data for covariates in the regions Marche,
Campania, Basilicata, Calabria, and Sicilia make it impossible to use data from
these regions as well. The regions Piemonte, Lombardia, Trentino-Alto Adige,
Emilia-Romagna, and Toscana are the only regions having good quality data
for both data sources.
5.3 Results
5.3.1 Who uses ART? Individual characteristics of mothers
The descriptive results underpin the data shown for many countries earlier in
this report, demonstrating that in Italy, women who seek ART treatment and
have a birth are on average older (average age is 35.7 years) than those who
conceived naturally (31.8 years). Most of them are experiencing a first birth
(81 per cent versus 51 per cent). In Figure 24, we compare the age pattern of
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first births by type of conception. Not surprisingly, those who conceived due to
ART treatment are clearly older. The modal age for the first birth is 31 years
for a natural conception and 36 years for births conceived after ART treatments,
and in the latter case the percentages of births remain high until around age 40.
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Figure 24: Type of conception by mother’s age in Italy
Source: CEDAP (2009), own calculations.
Among fathers, a smaller age difference is observed: 38.6 years for those
whose partners underwent ART versus 35.4 years for those who conceived their
child naturally. With regard to socio-demographic characteristics mothers who
used ART are more often married, more educated and less often foreign citizens
(8 per cent versus 18.7 per cent). They had more frequently experienced one or
more spontaneous miscarriages before delivery (but those differences disappear
once we control for age).
In a logit model, we verify whether these results hold also net of other factors.
Results presented in Figure 25 show that compared to those giving birth in their
twenties, mothers having a child in their thirties are more than four times more
likely to have used ART, while the odds ratio increases up to 14 if they give birth
in their forties. They are also more likely to be at first birth, net of other factors.
Italian mothers are 69 per cent more likely to use successful ART treatment than
foreigners. They are also substantially more likely to be married. Surprisingly,
the effect of employment status is small in magnitude (working mothers are
22 per cent more likely to have used ART), as well differences in educational
attainment. Having experienced previous miscarriages increase the probability
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to have used ART to conceive by 14 per cent, net of other factors such as age.
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Figure 25: Predictors of giving birth after ART (as opposed to natural concep-
tion), logit model. Odds ratios and 95 per cent confidence intervals.
Source: CEDAP (2009), own calculations.
5.3.2 How do ART pregnancies and deliveries differ from non-ART
ones?
We contrast the risk of having a premature delivery or a cesarean section for
those mothers who have conceived via ART with those who conceived naturally
in Table 2. Controlling for women’s characteristics and also for type and number
of medical check-ups during the pregnancies, we estimated that mothers who
conceived by ART (versus those who conceive without ART) have 54 per cent
higher odds to give birth between the 32nd and the 38th week of gestation and
a 59 per cent higher probability to have either a planned or urgent cesarean
delivery.
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Table 2: Odds of premature birth and c-section by type of conception
Premature birth Cesarean section
ART (Ref. natural conception) 1.54 (1.37–1.74) 1.59 (1.48–1.70)
Source: CEDAP (2009), own calculations. Notes: 95 per cent confidence intervals in paren-
theses. Controlling for women’s characteristics, such as age, educational level, marital status,
occupational status, and check-ups during pregnancy (e.g. number of ecographies, visits, pre-
natal diagnosis)
5.3.3 Variation in ART treatments and probability to have a suc-
cessful live birth
The combination of data sources (CEDAP and AS)—although possible only for
selected regions (see previous data description)—, allows us to verify whether
the risk of having a live birth versus an adverse outcome (either a miscarriage
or a stillbirth) differs between those who used ART and those who did not
(Figure 26). The probability of having a live birth seems to be unaffected by
the use of ART, with the exception of IVF, which seems even to give a 30 per cent
higher chance to have a live birth than natural conception, other things being
equal. This remarkable finding shows even though we are controlling for age,
citizenship, marital status, labor market status, education, previous live births,
and previous miscarriages.
5.4 Case study conclusions
This section provided analyses of a unique combination of administrative mi-
crodata sources to study the ART use in Italy. In particular, the data allows us
to compare the profiles of mothers, the outcomes of pregnancies and deliveries
of mothers having used ART to conceive. There are no previous studies in Italy
based on micro data on this issue.
If the rise in late fertility fuelled the rapid diffusion of various types of As-
sisted Reproductive Technologies (ART), the use of ART treatment contributed
to the accentuated fertility postponement among the Italians. Not surprisingly,
the over 40s and childless women are the most likely to use ART. Net of other
factors, ART usage is not clearly over-represented among more educated and
employed mothers, which can be interpreted as a sign of a spread of equal usage
over social classes.
Conception by ART is linked to (perceived) higher risk pregnancies and
deliveries, and as a consequence they turn to be are clearly more medicalised.
Those who conceived via ART have a higher risk of severely premature births
and cesarean deliveries, but in most cases this is explained by a higher risk of
multiple births. The probability of having a live birth versus either a miscarriage
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Figure 26: Predictors of giving live birth (as opposed to stillbirth and miscar-
riage), logit model. Odds ratios and 95 per cent confidence intervals.
Source: CEDAP (2009), own calculations.
or a still birth is not affected significantly by the method used among the ART.
A younger age and a reproductive history not characterised by miscarriages are
factors of reproductive success also among the ART users.
The recourse to ART by using the FIVET method seems to increase the
probability to have a live birth compared to a birth by natural conception,
while there is not a statistically significant association between the other ART
methods and natural conception in the chance to have a successful outcome.
In conclusion, we can state that ART represents an important opportunity
for Italian women who have difficulties in getting pregnant, but they also present
some risks. These results are also useful to discuss the opportunity to subsidize
ART treatments as a demographic or health policy, in order to know the possible
efficacy of the treatments in term of successful outcomes.
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6 Conclusions
6.1 Summary of main results
6.1.1 ART is not an effective policy measure to counter low fertility,
but usage has grown over time and varies across nations largely
due to differences in affordability and normative values
In this report, our aim was to document the demographic consequences of ART,
which was achieved by focusing on four central research aims. Our first aim was
to answer the highly pertinent policy question: Is ART a useful policy mecha-
nism to counter low levels of fertility? To tackle this question, we went beyond
research that only examined the proportion of ART births as total national
births across countries to look at research that included the more accurate mea-
sure of the ‘net impact’ of ART on national fertility rates. We concluded that
when we examine the more accurate measure of ‘net impact’ of ART on national
fertility rates, ART has a negligible impact on national fertility rates, thereby
suggesting that ART treatments would not be an effective policy instrument to
counter low fertility.
By virtue to answering this question, we also explored the large cross-
national differences across Europe in the proportion of ART births and potential
reasons for these variations. We found a large variation from around 1.5 per
cent in countries such as Turkey, Moldova, Poland and Ireland to above 4 per
cent (Iceland, Norway, Iceland, and Belgium) and even almost six per cent in
Denmark. We then attempted to understand why these differences existed by
posing and exploring five central hypotheses. First, we found no support for
our ‘postponement hypothesis’ that later age at first births in countries was
linked to the growth in ART. It may be that poor effectiveness at later ages and
the high number of unsuccessful births at advanced ages, however, masked this
link. Second, we found support for our expectation that the increased demand
in children—using the proxy of the TFR—was linked to high ART usage.
A third expectation found no clear evidence, with country affluence was not
a driving force behind ART usage. We concluded that this was likely too crude
of a measure with considerable ‘noise’ and was therefore impotent in uncovering
any association. We therefore turned to a fourth hypothesis, which measured
the affordability of treatments. Here we found that this more nuanced measure
was indeed a strong predictor driving ART utilization. Fifth, we explored the
power of cultural values particularly in relation to values regarding whether
a human embryo is considered human directly after fertilization. In countries
with a lower moral and ethical stance attached to embryos, there was a strong
association with higher ART births rates.
We also examined how ART birth rates changed over time from 1997 to
2010. Although there is considerable variation in ART birth rate levels between
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countries, we found a clear pattern of upward growth over time across all coun-
tries. This was with the exception of Germany, where a large policy change in
reimbursement rates in 2004 resulted in a drop in ART.
6.1.2 Perceived infertility differs widely across nations and there is
increased usage over age 40, where it is least effective
A second aim of this report was to examine ART usage at later ages and how this
varies across countries and effectiveness particularly at later ages. It is difficult
to obtain accurate estimates on the onset of infertility and detailed disaggregated
data at older ages. For this reason, we first examined an alternative measure of
self-reported infertility.
We illustrated that there are large national differences in self-perceived in-
fertility, particularly between the ages of 35 to 39 and within this group between
different countries. For women, there were particularly high rates of perceived
own infertility at around ten per cent in nations such as Austria, Belgium, Ro-
mania and the Czech Republic, compared to much lower levels of five per cent
in many countries. In most countries, the men in the same age group reported
generally low levels below five per cent.
We also found a strong increase of ART users at advanced ages above 40,
with sharp variations by country and the type of treatment. The majority of
ART treatments (around 45 per cent) still take place at age 34 years and under,
followed by those between 35 to 39 (around 38 per cent), with around 17 per cent
aged 40 and above. There was a strong growth in the ART usage by women over
40 between 1998 and 2000, particularly in Iceland, Denmark, and Italy. We then
broke down these differences between age group, country, and type of treatment.
In general, there was a similar age pattern as stated above for those seeking IVF,
ICSI, and FER treatment. Egg donation showed a markedly different pattern
of the majority of women above 40 years of age, which is not surprising since
the need for egg replacement is related to the depletion of fertility at later ages.
Here, around seventy per cent of those receiving donated eggs were above 40
years of age.
Since there was a surge in older women receiving these treatments, we found
that the effectiveness of these treatments were very low at older ages. We
found that higher maternal age is paired with a decreased success rate of IVF
treatments for those aged 40 and over of around ten per cent (delivery) and
twenty per cent (pregnancy), compared to those who were 34 years and under
at thirty per cent (delivery) and 35 per cent (pregnancy), respectively. A similar
drop is shown for ICSI and FER, with FER having the lowest success rates, even
women 34 and younger.
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6.1.3 Dramatic increase in twinning rates largely attributed to ART
and not birth postponement
The third aspect of this study demonstrated the explicit demographic conse-
quences of ART in relation to a growth in multiple births, particularly twins,
in relation to ART treatments. We showed that there has been a dramatic
increase in twinning rates since the 1970’s, with rates more than doubling in
many countries from the mid-1970’s to the early 2000’s. Since there have also
been strong increases in maternal age at birth, which is linked to twinning, we
explored whether it was birth postponement or ART that contributed to the
growth of the twinning rate. We demonstrated that the majority of the changes
in the twinning rate—or around two-thirds—can be attributed to ART, com-
pared to only around one-third related to the advanced age at childbearing. We
then linked this to multi-embryo transfer policies, which have shown consider-
able heterogeneity in the move towards single embryo transfer (SET). Yet we
note that a general shift in a lower number of embryo transfers over time in
many nations can be related to an (expected) drop in the twinning rates.
6.1.4 ART pregnancies and deliveries can be more problematic
The fourth goal of our report was to go beyond aggregated macro-level data and
use micro-level individual data to answer key questions that evade aggregated
figures. Using Italy as a case study, we examined the characteristics of ART
mothers and examined the variation by the type of ART and probability to have
a successful birth outcome. We found that, echoing our aggregated results, ART
users were older (on average 35.7 years) than those who conceived naturally,
but more interestingly the new information gained from this individual level
analysis was that it was more often for first births, married, higher educated,
native Italians that had previously experienced a miscarriage.
ART pregnancies and deliveries also differed significantly from those from
natural conception. ART mothers were more likely to deliver prematurely and
have a higher probability of a caesarean section. However, an interesting result
was that the probability of having a live birth did not differ between those with
and without ART treatments. In fact, those who underwent an IVF treatment
had a thirty per cent higher chance for a live birth than those who conceived
naturally, also controlling for multiple factors (e.g., age, education, miscarriage
history).
6.2 Policy recommendations and future research direc-
tions
ART is often heralded as a potential policy solution for low fertility. We ex-
amined research that predicted the net impact of ART live births, which is
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the difference between the observed number of births and a hypothetical one
achieved in the absence of ART treatments. The net impact is a smaller, but
also more realistic measure of the impact of ART since it takes into account that
couples who undergo ART treatment might spontaneously conceive and the un-
planned extra multiple births. Under realistic conditions, the net contribution
of ART on the overall birth rate ranges from 0.04 (Habbema et al., 2009; Leri-
don and Slama, 2008) to 0.06 (Sobotka and Testa, 2008), suggesting that view
that ART might have a substantial impact on fertility rates are exaggerated.
We can therefore conclude that ART has a negligible impact on national fertility
rates, thereby suggesting that ART treatments would not be an effective policy
instrument to counter low fertility.
The strongest associations driving cross-national differences in ART success
were affordability of treatment and ethical values regarding when an embryo is a
human, influencing the number of embryo replacements. Future policy directives
that would like to increase access to ART or understand why or why not certain
policies may work should not only prioritize affordability and economic aspects,
but consider the oft-forgotten normative and cultural values surrounding human
embryos.
Although the number of women 40 and older aspiring ART treatment has
grown over time, a striking finding of this study is that success rates for this
group are markedly lower. With the chance of around ten per cent for a success-
ful birth in some treatments such as IVF, the question remains as to whether
women and couples at these advanced ages are aware of the very low chances
(Maheshwari et al., 2008; Wyndham et al., 2012). Future policy directives
should focus on ensuring that this growing group of ART users and postponers
above the age of 40 are aware of the limited success rates of ART at advanced
ages. Kocourkova et al. (2014) suggest that ART can be a greater driving factor
in fertility rates if it is used earlier in women’s life rather than later. While this
is of course true, one of the most important reasons for the growing demand for
ART is the postponement of childbearing, which is a larger policy question.
In this report we also demonstrated that ART treatments have had explicit
demographic consequences in the form of a dramatic growth in the twinning rate.
The growth of multiple births highlights the importance of ART regulations
related to multiple embryo placement due to the important health risks for
both children and their mothers.
A central shortcoming of this study was that we often lacked detailed individual-
level data in our analyses. Certain aspects have also evaded measurement until
now, such as infertility, which is difficult to assess when defined as having prob-
lems to conceive naturally for at least one year. These questions are rarely asked
in surveys. We therefore turned to data on self-reported infertility, which also
appeared to vary widely by countries, suggesting that norms and non-biological
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factors may also play a strong role.
In our examination of ART treatments and success rates at older ages, we
were also left with an examination of only broad age groups of younger than 34
years, 35–39 years, and 40 years and older. Particularly for the group above 40,
it would be important to know at just what age thresholds women have more
problems achieving a healthy pregnancy.
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Gerda Neyer, Ariane Pailhé, Antonella Pinnelli, and Anne Solaz, 2007. ‘Gen-
erations and Gender Survey (GGS). Towards a Better Understanding of Re-
lationships and Processes in the Life Course.’ Demographic Research 17(14):
389–440. doi: 10.4054/DemRes.2007.17.14.
Wang, Yueping Alex, Michael Chapman, Michael Costello, and Elizabeth Anne
Sullivan, 2010. ‘Better Perinatal Outcomes Following Transfer of Fresh
Blastocysts and Blastocysts Cultured from Thawed Cleavage Embryos. A
Population-Based Study.’ Human Reproduction 25(6): 1536–1542. doi:
10.1093/humrep/deq067.
61
Williams, Carrie and Alastair Sutcliffe, 2009. ‘Infant Outcomes of As-
sisted Reproduction.’ Early Human Development 85(11): 673–677. doi:
10.1016/j.earlhumdev.2009.08.055.
Wright, Victoria C., Laura A. Schieve, Meredith A. Reynolds, and Gary Jeng,
2005. ‘Assisted Reproductive Technology Surveillance. United States, 2002.’
Morbidity and Mortality Weekly Report Surveillance Summaries 54(SS-2): 1–
23.
Wright, Victoria C., Laura A. Schieve, Meredith A. Reynolds, Gary Jeng, and
Dmitry M. Kissin, 2004. ‘Assisted Reproductive Technology Surveillance.
United States, 2001.’ Morbidity and Mortality Weekly Report Surveillance
Summaries 53(SS-1): 1–20.
Wright, Victoria Clay, Jeani Chang, Gary Jeng, Michael Chen, and Maur-
izio Macaluso, 2007. ‘Assisted Reproductive Technology Surveillance. United
States, 2004.’ Morbidity and Mortality Weekly Report Surveillance Summaries
56(SS-6): 1–22.
——, 2008. ‘Assisted Reproductive Technology Surveillance. United States,
2005.’ Morbidity and Mortality Weekly Report Surveillance Summaries 57(SS-
5): 1–24.
Wright, Victoria Clay, Jeani Chang, Gary Jeng, and Maurizio Macaluso, 2006.
‘Assisted Reproductive Technology Surveillance. United States, 2003.’ Mor-
bidity and Mortality Weekly Report Surveillance Summaries 55(SS-4): 1–22.
Wyndham, Nichole, Paula Gabriela Marin Figueira, and Pasquale Patrizio,
2012. ‘A Persistent Misperception. Assisted Reproductive Technology Can
Reverse the “Aged Biological Clock”.’ Fertility and Sterility 97(5): 1044–
1047. doi: 10.1016/j.fertnstert.2012.02.015.
Zanini, Giulia, 2011. ‘Abandoned by the State, Betrayed by the Church. Italian
Experiences of Cross-Border Reproductive Care.’ Reproductive Biomedicine
Online 23(5): 565–572. doi: 10.1016/j.rbmo.2011.08.007.
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